The glioblastoma multiforme (GBM) treatment market size is on a steep growth trajectory, rising from $2.73 billion in 2025 to ...

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

A new CAR-T cell therapy has shown promising early results against glioblastoma, a highly aggressive brain cancer. In a phase ...

A new liposome-based therapy delivers two drugs directly to glioblastoma cells, overcoming delivery barriers. When combined ...

When Jennifer Cosat arrived at St. Thomas More Hospital in 2006 with a headache, she didn’t know she was hours away from ...

Privilege in healthcare is shaped by geography, timing and a patient's ability to navigate an unforgiving system while in crisis.

A California husband and wife, Zak and Cori Salazar, with three children are still battling cancer together more than two ...

In April 2022, my mother-in-law, Karla, went for a routine physical therapy visit for carpal tunnel pain. The clinic was full and nearly turned her away. Only after she insisted that something felt ...

Alpha Tau’s IMPACT trial is expected to enroll up to 30 patients across the U.S., Canada, and Israel, focusing on patients ...

RICHMOND, Va. (WRIC) — Virginia Commonwealth University (VCU) Massey Comprehensive Center has debuted a new first-in-market brachytherapy brain tumor surgery to treat glioblastoma, according to ...